ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 165 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $2,327,000 | -61.0% | 170,000 | -79.0% | 0.90% | -22.4% |
Q2 2016 | $5,969,000 | +7.5% | 807,700 | -7.0% | 1.15% | +15.6% |
Q1 2016 | $5,551,000 | +41.0% | 868,700 | +37.9% | 1.00% | +6.6% |
Q4 2015 | $3,938,000 | +11.5% | 630,000 | +4.1% | 0.94% | +58.7% |
Q3 2015 | $3,533,000 | -32.7% | 605,000 | -4.7% | 0.59% | -43.9% |
Q2 2015 | $5,251,000 | +0.4% | 635,000 | 0.0% | 1.05% | -20.8% |
Q1 2015 | $5,232,000 | +75.1% | 635,000 | +46.0% | 1.32% | +43.2% |
Q4 2014 | $2,988,000 | +268.9% | 435,000 | +190.0% | 0.92% | +600.8% |
Q3 2014 | $810,000 | – | 150,000 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |